IRIS
TRAVELLI, Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 928
NA - Nord America 806
AS - Asia 260
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.995
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 789
IE - Irlanda 264
IT - Italia 203
SE - Svezia 137
DE - Germania 136
UA - Ucraina 85
CN - Cina 72
HK - Hong Kong 55
IN - India 49
FI - Finlandia 36
SG - Singapore 33
TR - Turchia 30
FR - Francia 23
CA - Canada 17
GB - Regno Unito 16
IR - Iran 10
BE - Belgio 8
VN - Vietnam 8
CZ - Repubblica Ceca 6
LT - Lituania 5
RU - Federazione Russa 5
GR - Grecia 3
CH - Svizzera 1
EU - Europa 1
ID - Indonesia 1
PH - Filippine 1
TH - Thailandia 1
Totale 1.995
Salva come PNG Salva come JPEG
Città #
Dublin 264
Jacksonville 163
Dearborn 86
Piemonte 78
Hong Kong 55
Chandler 54
Wilmington 48
Ann Arbor 47
Bremen 28
Lawrence 28
Princeton 28
Beijing 25
Ashburn 20
Singapore 20
Ankara 19
San Mateo 17
Toronto 16
Strasbourg 13
Woodbridge 13
Andover 12
Nanjing 12
Kecioeren 10
Formigine 9
Varallo 9
Brussels 8
Dong Ket 8
Hefei 8
Houston 8
Leawood 8
Milan 8
Brno 6
Helsinki 6
Zanjan 6
Berlin 5
Boardman 5
Kaunas 5
Torino 5
Albano Laziale 4
Chengdu 4
Mülheim 4
Nanchang 4
Vaiano Cremasco 4
Athens 3
Bacoli 3
Fairfield 3
Grignasco 3
Guangzhou 3
Munich 3
Shanghai 3
Turin 3
Cagliari 2
Cambridge 2
Dallas 2
Genoa 2
Hangzhou 2
Kunming 2
Monmouth Junction 2
Norwalk 2
Novokuznetsk 2
Omegna 2
Paris 2
Pavia 2
Saluggia 2
Ardabil 1
Auburn Hills 1
Bangalore 1
Baotou 1
Bari 1
Bois-le-roi 1
Changsha 1
Chelyabinsk 1
Como 1
Eskişehir 1
Falkenstein 1
Fuzhou 1
Gravedona 1
Hamilton 1
Hebei 1
Hyderabad 1
Jakarta 1
Jinan 1
London 1
Los Angeles 1
Monza 1
Morlon 1
Novara 1
Nuremberg 1
Occimiano 1
Saint Louis 1
Savignano Sul Rubicone 1
Seattle 1
Shenyang 1
Tehran 1
Vercelli 1
Volzhskiy 1
Zhengzhou 1
Totale 1.263
Salva come PNG Salva come JPEG
Nome #
Identification of a novel NAMPT inhibitor by combinatorial click chemistry and chemical refinement 114
Inhibitors of Nicotinamide Phosphoribosyltransferase, compositions, products and uses thereof. 104
The NAMPT inhibitor FK866 reverts the damage in spinal cord injury 97
Identification of Novel Triazole-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors Endowed with Antiproliferative and Antiinflammatory Activity 96
Design, synthesis, and biological evaluation of combretabenzodiazepines: a novel class of anti-tubulin agents 95
Combretabenzodiazepines: a novel class of antitubulin agents 94
Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions. 91
Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders 88
Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors. 80
Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is a tumoural cytokine released from melanoma 78
Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin): a new cytokine in tumour progression 73
Triazole-curcuminoids: A new class of derivatives for 'tuning' curcumin bioactivities? 70
A novel potent nicotinamide phosphoribosyltransferase inhibitor synthesized via click chemistry 68
Synthesis and Degradation of Adenosine 5'-Tetraphosphate by Nicotinamide and Nicotinate Phosphoribosyltransferases 68
Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors: novel modulators of antitumor immunity 65
Increased plasma nicotinamide phosphoribosyltransferase is associated with a hyperproliferative phenotype and restrains disease progression in MPN-associated myelofibrosis 65
Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin): a new cytokine in tumour progression 62
Targeting nicotinamide phosphoryltransferase (NAMPT) in inflammatory bowel disease 62
Metabolic regulation of suppressive myeloid cells in cancer 61
Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine 59
Characterization of NAD uptake in mammalian cells 58
NAMPT: A pleiotropic modulator of monocytes and macrophages 57
Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors are novel modulators of myeloid-derived suppressor cells 56
Data on metabolic stability, aqueous solubility and CYP inhibition of novel triazole-based nicotinamide phosphoribosyltransferase (NAMPT) inhibitors 54
The Cytokine Nicotinamide Phosphoribosyltransferase (eNAMPT; PBEF; Visfatin) Acts as a Natural Antagonist of C-C Chemokine Receptor Type 5 (CCR5) 52
NAD depletion by FK866 induces autophagy 50
Reciprocal potentiation of the antitumoral activities of FK866, an inhibitor of nicotinamide phosphoribosyltransferase, and etoposide or cisplatin in neuroblastoma cells 49
Insight Into Nicotinamide Adenine Dinucleotide Homeostasis as a Targetable Metabolic Pathway in Colorectal Cancer 27
Extracellular nicotinamide phosphoribosyltransferase boosts IFNγ-induced macrophage polarization independently of TLR4 26
OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression 22
Identification of novel aza-analogs of TN-16 as disrupters of microtubule dynamics through a multicomponent reaction 19
NAMPT and NAPRT serum levels predict response to anti-TNF therapy in inflammatory bowel disease 11
Synthesis and Degradation of Adenosine 5'-Tetraphosphate by Nicotinamide and Nicotinate Phosphoribosyltransferases 9
Totale 2.080
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.598
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.598
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020356 4 1 27 1 52 54 81 17 36 45 37 1
2020/2021243 31 3 29 1 31 21 33 3 35 15 30 11
2021/2022237 19 3 22 21 17 2 14 6 15 15 30 73
2022/2023635 31 23 34 5 50 63 26 34 296 7 38 28
2023/2024222 24 15 35 10 33 0 49 4 3 1 23 25
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 2.080